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A B S T R A C T
Health promotion interventions can be improved using methods from behavioural economics to identify and
target speciﬁc decision-making biases at the individual level. In this context, prospect theory provides a suitable
framework within which decision-making processes can be operationalised. Focusing on a trade-oﬀ between
health outcomes and behaviour change incurred by chronic disease management (lifestyle change, or ‘self-
management’), we are the ﬁrst to measure the risk attitudes and quantify the full utility function under prospect
theory of a patient population. We conducted a series of hypothetical elicitations over health outcomes asso-
ciated with diﬀerent self-management behaviours from a population of individuals with or without ‘manageable’
chronic disease (n=120). We observed risk aversion in both the gain and the loss domains, as well as signiﬁcant
loss aversion. There seems to be an age eﬀect on risk attitudes in this context, with younger people being on
average less risk averse than older people. Our work addresses a need to better understand these decision-
making processes, so that behaviour change interventions tailored to speciﬁc patient populations can be im-
proved.
1. Introduction
People are constantly faced with choices under conditions of un-
certainty. In the health domain, for example, patients have to decide
whether to take a treatment or not, considering both its beneﬁts (health
outcomes) and costs (side eﬀects), which may carry signiﬁcant un-
certainty. With the progress of medicine, an increasing number of
chronic diseases have become ‘manageable’, leading to new types of
trade-oﬀs. Type 2 diabetes mellitus (T2DM; the non-insulin dependent
form of the disease) is a good example of this: if well controlled, people
with T2DM can expect health outcomes similar to the average person
(i.e. broadly equivalent life expectancy and quality of life) (Lutgers
et al., 2009; Redekop et al., 2002). However, having good control of the
disease requires adhering to a certain number of lifestyle changes (‘self-
management of the disease’, including adopting a healthy diet, enga-
ging into regular physical activity, being adherent to medications, etc.)
(American Diabetes Association., 2017; Shrivastava et al., 2013; Norris
et al., 2001) and in practice a signiﬁcant proportion of patients fail to
change their behaviour once diagnosed (Peyrot et al., 2005;
Bodenheimer et al., 2002). As a result, people who do not change their
behaviour may have fewer commitments in their daily life but may
subsequently be more likely to suﬀer from complications that could
have been avoided.
In this context, there is a need for more eﬀective interventions that
encourage people with chronic disease to change their behaviour
(Rouyard et al., 2017). Over the past ten years, there has been in-
creasing interest in using concepts and methods from behavioural
economics to inform health interventions (see e.g. Luoto and Carman,
2014; Loewenstein et al., 2012; Petry et al., 2013). Located at the in-
terface of decision theory, economics and psychology, behavioural
economics assumes that normative theories of choice provide an un-
realistically rational account of how people make decisions (Waters
et al., 2013; Sutton, 2001) and promotes the development and appli-
cation of more descriptive theories of choice for policy-making pur-
poses. Known as nudges, interventions based on behavioural economics
aim to target systematic biases (or ‘irrationalities’) identiﬁed in people's
decision-making processes to ‘nudge’ people towards a given re-
commended behaviour (Thaler and Sunstein, 1999). For example,
people tend to discount delayed rewards, such as avoiding cancer or
heart disease, relative to more immediate, smaller rewards, such as
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having a cigarette or an extra dessert now (‘present biasedness’). In a
recent study, Mørkbak et al. (2017) showed that present biasedness was
associated with earlier onset of diabetes and lower ability to manage
chronic disease. This supports the development of interventions aiming
to mitigate the eﬀect of this bias (e.g. incentives or monetary-based
rewards) to increase adherence to self-management in these popula-
tions. Such interventions have shown promising results in encouraging
weight loss (Volpp et al., 2008), enhancing exercise (Petry et al., 2013),
or improving medication adherence (Petry et al., 2015).
We aim to contribute to this literature by exploring the risk attitudes
of people facing (risky) behavioural choices associated with chronic
disease management. Risk attitudes is known to play a key role in the
decision-making process (Weber and Milliman, 1997; Sitkin and
Weingart, 1995) and risk seeking behaviour could explain, at least
partly, non-adherence to self-management behaviour. In this context,
prospect theory (PT) (Kahneman and Tversky, 1979) provides a good,
tractable way of operationalising people's decision-making processes. It
allows exploring risk attitudes together with three decision-making
biases potentially helpful to design better targeted nudge interventions:
reference point (RP) dependence (people evaluate outcomes relative to
an RP, and then classify them as gains and losses), probability
weighting (people tend to overweight less likely events and under-
weight more likely ones) and loss aversion (‘losses loom larger than
commensurate gains’, i.e. the pain of losing is psychologically more
powerful than the pleasure of gaining) (see e.g. Kahneman and Tversky,
1979; Tversky and Kahneman, 1992). For monetary outcomes, nu-
merous empirical studies have shown the existence of PT biases. For
health outcomes, however, the literature is still sparse. This is an issue
since signiﬁcant diﬀerences exist between health utility and utility for
money (Attema et al., 2013). This may partly explain why nudges
aiming to increase adherence to self-care behaviours – which rely on
biases identiﬁed with monetary outcomes – have shown mixed results
so far (see Kullgren et al., 2017 for a review in T2DM populations). To
our knowledge, only two studies have measured utility under PT with
health outcomes. First, focusing on utility for life duration, Attema et al.
(2013) found evidence of loss aversion and risk aversion with respect to
both gains (slightly concave utility) and losses (concave utility) in a
study conducted on a student population. Evidence of probability
weighting, more pronounced in the gain domain, was also reported.
Second, a recent study conducted on a general population sample found
similar trends with respect to the utility for quality of life (QoL) (Attema
et al., 2016). These ﬁndings challenge, in part, what is usually observed
with monetary outcomes. In particular, they contradict the S-shaped
utility function characteristic of PT, due to concave utility for losses.
In this study, we aim to quantify the full utility function under PT
(i.e. utility parameters and loss aversion coeﬃcient) of a population
that includes people living with a chronic condition, using outcomes
that include both dimensions of health utility: life duration and QoL.
Conducting the study on patients is crucial to better understand speciﬁc
decision-making processes that will help design tailored nudge inter-
ventions. This study is the ﬁrst to do so. Using a recent method of utility
elicitation under PT in the health domain, we measure people's risk
attitudes by investigating their trade-oﬀs between health outcomes
associated with diﬀerent self-management behaviours. More speciﬁ-
cally, we analyse risky decisions through the lens of the three decision-
making biases embedded into PT: a) RP dependence; b) probability
weighting; and c) loss aversion.
Our results show that people express a high degree of risk aversion,
both in the gain and in the loss domains, and signiﬁcant loss aversion.
This is in contrast with the ﬁndings using monetary outcomes and
suggests that the role of the RP may be less crucial for health than it is
for money. There seems to be an age eﬀect on risk attitudes, with
younger people being on average less risk averse than older people.
Finding evidence of risk aversion for both gains and losses in this study
suggests that risk seeking behaviour does not explain lack of adherence
to self-management in T2DM populations. Our results support the
design of interventions that raise awareness of diabetes-related health
risks and take advantage of people's loss aversion.
2. Method
Our method follows Attema et al. (2013)'s semi-parametric method
of utility elicitation in the health domain. It uses certainty equivalents
(CEs) to measure the parameters of a speciﬁc utility function (ex-
ponential parametric family). CEs are elicited through a series of
choices over binary prospects involving diﬀerent life durations. How-
ever, we expand on this work by adding a QoL dimension to the out-
comes, so that preferences based on more realistic scenarios for health-
related behaviour change can be captured. The use of quality-adjusted
life years (QALY) outcomes allows quantifying similarly both the dis-
utility of engaging in self-care behaviour and the disutility of suﬀering
from disease-related complications.
2.1. Model
Let p x y( , ; ) denote a binary prospect that gives outcome x QALYs
with probability p and outcome y QALYs with probability − p1 . Gain
prospects [loss prospects, mixed prospects] imply that ≥ ≥x y 0
[ ≤ ≤x y 0, > >x y0 ]. According to PT, evaluation of prospects can be
represented by the following equations, where +w p( ) [ −w p( )] is the
decision weight associated with the ﬁxed probability p in the gain
[loss] domain, and u x( )[u y( )] denotes the utility associated with the
outcome x[y]:
= × − ++PT p x y w p u x u y u y( , ; ) ( ) ( ( ) ( )) ( ) for gain prospects; (1)
= × − +−PT p x y w p u x u y u y( , ; ) ( ) ( ( ) ( )) ( ) for loss prospects, and;
(2)
= × + − ×+ −PT p x y w p u x w p u y( , ; ) ( ) ( ) (1 ) ( ) for mixed prospects.
(3)
The semi-parametric method entails three stages. First, eliciting CEs
of a series of two-outcome gain prospects (diﬀerent outcomes, but same
probability for all prospects) allows us to identify the utility function for
gains and the decision weight +w p( ). By assuming PT and a particular
parametric shape of the utility function, it is indeed possible to estimate
the parameters of the function and the decision weight of the prob-
ability that best ﬁt the elicited data. Second, the same steps need to be
performed in the loss domain. Finally, both utility functions can be
connected through the elicitation of the maximum loss amount that a
subject is willing to accept in a mixed prospect including one of the gain
outcomes used in the ﬁrst stage. This enables estimation of the loss
aversion coeﬃcient λ, allowing comparison between gain utilities and
loss utilities. Details are provided in the following subsections. This
semi-parametric method has several advantages compared to fully and
non-parametric methods. Firstly, measurements are not confounded by
assumptions about the shape of the probability weighting function.
Secondly, it is less time-consuming for the respondent because fewer
questions are needed to elicit the CEs (Abdellaoui et al., 2008).
2.2. Elicitation of utility parameters and decision weights
The method assumes that observable U is a composition of λ and a
basic utility u, with:
= ⎧⎨⎩
≥
<U x
u x if x
λu x if x
( )
( ) 0
( ) 0 (4)
Following Attema et al. (2013), we consider the exponential family
of utility functions for both utilities of gains and losses:
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⎧
⎨⎩
=
=
− −
−
u x for gains
u x for losses
( ) ;
( ) ;
γx
γ
δx
δ
1 exp( )
exp( ) 1
(5)
With risk aversion coeﬃcients ≠γ δ, 0. For γ , =δ 0, =u x x( ) .
For each prospect i in the gain [loss] domain, we elicit a CEi such
that the respondent is indiﬀerent between gaining [losing] CEi QALYs
for certain and the prospect that provides a 50% chance of gaining
[losing] a higher amount xi QALYs and 50% chance of gaining [losing]
a lower amount yi QALYs. Then, assuming PT and exponential utility
functions, this indiﬀerence can be described by the following equations:
• Gains:
From equation (1) and equation (5), we obtain:
⎜ ⎟
− − = ⎛
⎝
− − − − − ⎞
⎠
+ − −
+γCE
γ
ω γx
γ
γy
γ
γy
γ
1 exp( ) . 1 exp( )
1 exp( )
1 exp( )
;
i i i
i
(6)
with =+ +ω w (1/2).
Solving this expression for CEi gives the following regression
equation:
= − − − − + −
+
CE
ω γx γy γy
γ
ln[ . (exp( ) exp( )) exp( )]
i
i i i
(7)
From equation (7), it is possible to estimate both the utility function
parameter γ and the decision weight +ω , through non-linear least
squares.
• Losses:
From equation (2) and equation (5), we obtain:
⎜ ⎟
− = ⎛⎝
− − − ⎞⎠ +
−−CE ω x y yexp(δ ) 1
δ
. exp(δ ) 1
δ
exp(δ ) 1
δ
exp(δ ) 1
δ
;i i i i
(8)
with =− −ω w (1/2).
Solving this expression for CEi gives the following regression
equation:
= − +
−
CE
ω x y yln[ . (exp(δ ) exp(δ )) exp(δ )]
δi
i i i
(9)
Similarly, from equation (9), it is possible to estimate both the
utility function parameter δ and the decision weight −ω , through non-
linear least squares.
2.3. Elicitation of loss aversion parameter
We estimate the loss aversion coeﬃcient λ by determining the loss
outcome L* for which the participant is indiﬀerent between a prospect
giving a 50% chance of gaining an outcome G* and a 50% chance of
losing the outcome L*, and the status quo:
∼G L(½, ; ) 0* * (10)
From equation (3), this mixed prospect gives:
+ =+ −ω U G λ ω U L. ( ) . . ( ) 0* * (11)
Which, in terms of the exponential utility function; translates into:
− − + − =+ ∗ − ∗ω γG
γ
λ ω L. 1 exp( ) . . exp(δ ) 1
δ
0
(12)
Solving this expression for ∗L gives the following regression equa-
tion:
=
⎡⎣ − ⎤⎦∗
− −+
−
∗( )
L
ln 1 .
δ
ω
ω λ
γG
γ
.δ
.
1 exp( )
(13)
3. Experiment
3.1. Stimuli
We aim to elicit preferences, both in the gain and loss domains,
when the outcomes vary in terms of both life duration and QoL (see
3.3.c). As a result, participants make choices over outcomes quantiﬁed
in terms of QALYs.
The utility functions for both gains and losses were elicited by the
use of 5 CE questions each and one outcome G* was used to measure
loss aversion (see Table 1). Importantly, we introduced an RP of living
20 more years. The length of the RP was the result of a trade-oﬀ be-
tween two elements: tractability and realism. On the one hand, a large
RP was needed to allow variation in prospects over a suﬃciently wide
range of health outcomes. Setting up an RP of 20 years allowed us to
design loss prospects involving the potential loss of up to 15 years of
life. We decided not to design loss prospects involving the loss of up to
20 years of life (i.e. the totality of the RP), in order not to induce any
psychological stress or negative emotional reaction. The prospect of
dying ‘immediately’, that may have provoked anxiety, was thus ruled
out as an option. On the other hand, because T2DM rarely occurs before
the age of 50, the average life expectancy of our population did not
provide us with much leeway to adopt a large RP. For the sake of
realism, we decided to exclude individuals aged above 60 from the
study (see 3.2). In this way, setting up a RP of 20 years led to the best-
case scenario of older participants reaching the maximum age of 95
years (60 years old + RP of 20 years of life + potential gain of 15 years
of life). Section 3.3.b provides more details on the elicitation procedure.
3.2. Participants
The sample includes 120 individuals between 30 and 60 years of
age. Sixty participants were living with T2DM, and 60 participants had
no diagnosis of T2DM or any other chronic disease. T2DM is a good
example of a manageable chronic disease: it often requires multiple
drug therapies, frequent monitoring of risk factors and regular health
care contacts, and good control is associated with better health out-
comes (life expectancy and QoL) (American Diabetes Association.,
2017; Shrivastava et al., 2013; Norris et al., 2001). This study received
ethics approvals from the competent UK research ethics committees
[ref. 16/NE/0203].
3.2.1. T2DM group
The inclusion criteria were: 1) aged between 30 and 60; 2) diag-
nosed with T2DM; 3) willing and able to give informed consent for
participation in the study. The exclusion criterion was: non-English
speaker. The rationale behind the lower age limit (30) is that T2DM is
rarely diagnosed before that age, while the upper age limit (60) was set
for experimental reasons, due to the RP of 20 years: the older the
subject, the more unrealistic the hypothetical scenarios used to elicit
risk preferences and the higher the risk of elicitation bias (see Appendix
A). Subjects in this group were familiar with the daily management of
T2DM (they had been informed and trained at diagnosis).
Table 1
List of stimuli used in the experiment (years of life [QALYs]).
j= 1 j= 2 j=3 j= 4 j=5 G*
|x| 6 [4.5] 10 [7.5] 12 [9] 15 [11.25] 15 [11.25] 10 [7.5]
|y| 0 [0] 0 [0] 0 [0] 5 [3.75] 9 [6.75]
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3.2.2. Control group
We formed a control group to examine risk preferences and PT
parameters in a comparable population who is not concerned with the
daily management of a chronic disease. The inclusion criteria were: 1)
aged between 30 and 60; 2) not diagnosed with T2DM or any other
chronic disease; 3) willing and able to give informed consent for par-
ticipation in the study. The exclusion criterion was: non-English
speaker.
3.3. Procedure
3.3.1. Recruitment
Subjects were recruited at a local surgery practice in the UK. Control
participants were patients between 30 and 60 coming to the surgery
practice for minor health issues and who kindly agreed to participate in
the study. In order to balance the sample in terms of age and gender, we
tried to recruit a similar proportion of subjects below and above 50 as
well as a similar proportion of men and women in both groups. Because
T2DM usually appears in the late 50/early 60 years of age, a major
challenge of the study was to ﬁnd ‘young’ eligible people (i.e. aged
below 50) diagnosed with the disease. Similarly, it was more diﬃcult to
recruit female participants than male participants in the T2DM group
because of the higher prevalence of T2DM in the male population.
After receiving information about the study from their general
practitioner (GP), consenting participants were presented with the on-
line questionnaire during a one-to-one interview with an experimenter.
The study took place in a private area of the surgery practice. The ex-
perimenter carefully explained each scenario and made sure that the
participant understood the instructions and the questions. It was made
clear that there were no right or wrong answers. Each subject received a
modest monetary incentive (£10) to participate in the study, as is
commonly done in the ﬁeld. The incentive was given at the end of the
survey, independently of the answers of the participant.
3.3.2. Questionnaire
A questionnaire speciﬁcally designed to elicit participants' risk
preferences was developed in collaboration with both health profes-
sionals and patients. We adapted existing questionnaires (Abdellaoui
et al., 2008) to ﬁt the population and outcomes of interest. In particular,
we took into account the suggestions of a small group of patients (4
volunteers) who were asked to provide feedback on user-friendliness
and comprehensibility. Indiﬀerences (i.e. the CEs) were elicited through
a series of binary choices. Each binary choice corresponded to an
iteration in a bisection process (see example in Table 2). In each choice
participants were faced with two prospects, labelled ‘option A’ and
‘option B’, where ‘option A’ was always riskless. Based on our group of
volunteers' feedback on the graphical features of the questionnaire,
prospects were displayed as ‘smiley chains’, with each smiley symbo-
lising a year of life, and accompanied by a short description (see ex-
ample in Fig. 1). A green smiley represented a year lived with perfect
QoL (100%), a yellow smiley a year lived with good QoL (75%), and a
red smiley a year lived with moderate QoL (50%). The order of the 5 CE
questions was randomised to avoid a potential order eﬀect (for both
gains and losses). Moreover, to control for response errors and check
the reliability of collected data, we repeated the ﬁrst iteration after the
ﬁnal iteration for 5 CE questions (j= 3 and j= 4 for both gains and
losses, and the mixed prospect) (Abdellaoui et al., 2008).
In Table 2, the prospect that is chosen in each iteration is printed in
bold. Starting values in the iterations were always selected so that
prospects had equal expected value. Depending on the choice made, the
certain outcome was increased or decreased (but was always an in-
teger). The method resulted in an interval within which the indiﬀerence
value should lie. The midpoint of this interval was taken as the in-
diﬀerence value. In this ﬁrst example, we started with prospects whose
expected value was 7.5 QALYs. The indiﬀerence value elicited for the
sure outcome was 4.9 QALYs, implying risk aversion.
3.3.3. Scenarios
The QoL dimension that we consider is a broad notion of health-
related QoL, which describes the three hypothetical scenarios used to
design the prospects. Each scenario is attributed with a score, expressed
in percentage points, on a scale ranging from 0 (worst possible health-
related QoL) to 100 (best possible health-related QoL), based on a de-
scription of the QoL associated with the scenario in question. The sce-
narios and their values were designed according to four criteria. First,
the scenarios should depict signiﬁcantly diﬀerent QoL scores, in order
to a) beneﬁt from suﬃcient leeway to design the prospects; and b)
create clear diﬀerences in the mind of participants. Second, the QoL
scores should be as easy to understand as possible for the participants.
Third, the QoL scores should also be as realistic as possible. Finally, the
scenario descriptions should not be over-precise, in order to avoid
‘rating biases’. We wanted the participants to imagine living with the
QoL score we set and to use a precise health state description to illus-
trate this score (e.g. ‘living with a QoL of 50% corresponds to living
with a lower extremity amputation’) would very likely create a bias,
depending on how the person actually rates the QoL of living with an
amputation. Such personal ratings could be much lower or higher than
50%, and studies such as Huang et al. (2007) have shown that the
scores patients with T2DM attribute to a given health state can be
widely heterogeneous.
Scenarios and corresponding scores are displayed in Table 3. We
used QoL scores drawn from a study which aimed to quantify patients'
utilities (i.e. measuring preferences) for the full array of diabetes-re-
lated complications and treatments (Huang et al., 2007). For scenario 1
(‘behaviour change; no complication’), we used the utility attributed to
life under ‘conventional glucose control’ (i.e. following a recommended
self-management behaviour but possibly experiencing side eﬀects due
to medications) and rounded it down to 75%. For scenario 3 (‘no be-
haviour change; complication’), we used the utility attributed to life
with a ‘lower extremity amputation’ and rounded it down to 50%.
These scores (75%, 50%) reﬂect a compromise which satisﬁes each of
the four criteria mentioned before and quantify the (dis)utilities in-
herent in the three scenarios (and thus allow the elicitation of CEs) but
are not intended to generate empirically grounded QALYs.
3.4. Analysis
3.4.1. CEs and risk attitudes
A participant was classiﬁed into the risk averse [risk neutral, risk
seeking] category for gains [losses] if he or she showed risk aversion
[risk neutrality, risk seeking] for at least four out of ﬁve CEs. Otherwise,
the person was classiﬁed into the mixed category for gains [losses]. This
allowed us to take into account a small margin of error in the responses.
Because the data were not normally distributed, we performed non-
parametric statistical tests. Within-subjects comparisons were made
using Wilcoxon signed-rank tests and between-subject comparisons
Table 2
An illustration of the bisection method (gains; j = 4).
Iteration Oﬀered choices in elicitation of G4 Expected value
(QALY)
1 10 years (75%) vs. [½, 15 years
(75%); 5 years (75%)]
7.5
2 5 years (75%) vs. [½, 15 years
(75%); 5 years (75%)]
3.8
3 8 years (75%) vs. [½, 15 years
(75%); 5 years (75%)]
6.0
4 6 years (75%) vs. [½, 15 years
(75%); 5 years (75%)]
4.5
5 7 years (75%) vs. [½, 15 years
(75%); 5 years (75%)]
5.3
Indiﬀerence value 6.5 years (75%) 4.9
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were made using Mann-Whitney U tests. In both cases, two-tailed p-
values are reported.
3.4.2. Utility and loss aversion parameters
The ﬁve types of individual parameters were estimated through
non-linear least squares regressions. For each participant, utility para-
meters (risk aversion coeﬃcients and decision weights) were calcu-
lated, in both domains, to best ﬁt the elicited data (i.e., the CEs) to the
non-linear functions described in equations (7) and (9). In the gain
[loss] domain, we estimated the values of +ω and γ [ −ω and δ] that
minimized the sum of squared residuals, i.e. the diﬀerence between the
elicited data and the ﬁtted value provided by the model ( +ω and −ω
were constrained between 0 and 1). After estimating the four utility
parameters, we estimated the loss aversion coeﬃcient based on equa-
tion (13). We also analysed the impact of observable characteristics by
running ordinary least squares (OLS) regressions on each parameter
estimate.
4. Results
4.1. Reliability
In order to check for answer consistency throughout the experiment,
we repeated the ﬁrst iteration, after the ﬁnal iteration, for ﬁve diﬀerent
CEs. Overall, 110 individuals provided consistent answers for at least
four out of ﬁve CEs (92%), indicating good reliability. In the T2DM
group [control group], 39 participants (65%) provided consistent an-
swers for the ﬁve CEs in both domains [49 participants (82%)], 13
participants (22%) for four out of ﬁve CEs [9 participants (15%)] and
only 8 participants (13%) for three out of ﬁve CEs [2 participants
(3%)]. In both groups, no participants gave inconsistent answers for
more than two out of ﬁve CEs. However, in order to minimise the bias
due to unreliable answers, we decided to exclude participants who were
not consistent for at least four out of ﬁve CEs. In the analysis, for
subjects who answered inconsistently for one CE (e.g. they ﬁrst ex-
pressed risk aversion for the CE, but then expressed risk seeking for the
same CE when repeating the ﬁrst iteration), we eliminated that CE and
classiﬁed the subject according to their other answers. Therefore, the
ﬁnal sample sizes for analysis are 52 (T2DM group) and 58 (control
group).
4.2. Characteristics of the participants
Table 4 presents a summary of the participants' characteristics in the
ﬁnal sample (n= 110). Chi-square tests show no signiﬁcant between-
group diﬀerences in terms of gender (p=0.14), employment status
(p= 0.23), education level (p= 0.32) or reliability (p=0.14). Ac-
cording to Mann-Whitney U tests, age diﬀerence was signiﬁcant
(p= 0.012) but time to complete the questionnaire was not (p= 0.39).
4.3. Utility for gains and losses
4.3.1. CEs and risk attitudes
Table 5 classiﬁes subjects according to their risk category in each
domain. It shows that half of the subjects (49%; 30 in the T2DM group
and 24 in the control group) were risk averse over the whole domain.
The second largest group is made up of people who were risk averse in
the gain domain and mixed in the loss domain (17% of the sample; 7 in
the T2DM group and 12 in the control group). A large majority of
subjects were classiﬁed into the risk aversion category for gains (70%),
Fig. 1. Example of prospects displayed as smiley chains (j = 1).
Table 3
Scenarios and associated QoL scores.
Scenario 1
Behaviour change;
No complication
Scenario 2
No behaviour change;
No complication
Scenario 3
No behaviour change;
Complication
Score QoL: 75% (good) QoL: 100% (perfect) QoL: 50% (moderate)
Source (Mean [SD])
(Huang et al., 2007)
Utility attributed to ‘conventional glucose control’ (0.76
[0.31])
- Utility attributed to ‘lower extremity amputation’ (0.55
[0.36])
Scenario description (Huang
et al., 2007)
Constraints in daily life linked to precautionary behaviour:
‘You will need to follow a diet, to exercise regularly, to see the
doctor regularly, and to take daily medications.’
‘For example, you may have to eat less of some foods you like,
or experience mild to moderate side eﬀects associated with
your medications.’
No health-related
constraints in everyday life
Constraints in daily life linked to a complication:
‘You might experience mild to moderate pain, tiredness, or
diﬃculties in performing daily tasks such as driving or
cleaning the house.’
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but only half of them for losses (55%). This diﬀerence in proportions is
signiﬁcant (p= 0.02). Between-group comparisons do not show sig-
niﬁcant diﬀerences in terms of proportion of subjects classiﬁed into the
risk averse and mixed categories with respect to gains (75% and 23% in
the T2DM group vs 66% and 24% in the control group, p=0.14 and
p=0.90, respectively); however, there is a trend towards signiﬁcant
diﬀerence for risk seeking subjects (2% vs 10%, p= 0.07). In the loss
domain, results are more mixed but there are no signiﬁcant diﬀerences
in terms of proportions.
Table 6 reports the medians and interquartile ranges of individual
CEs elicited in both groups. There is strong evidence for risk aversion, in
both the gain and the loss domains. For four out of ﬁve CEs (j= {2, 3, 4,
5}), risk aversion was higher in the gain domain. This diﬀerence is
signiﬁcant for j= {4, 5}. Conversely, for j= 1, risk aversion was sig-
niﬁcantly higher in the loss domain. Overall, 77% [7%, 16%] of the
elicited CEs conveyed risk aversion [risk neutrality, risk seeking] for
gains, whereas 65% [15%, 20%] conveyed risk aversion [risk neu-
trality, risk seeking] for losses. Median CEs elicited in the control group
were often higher than and always at least as high as those elicited in
the T2DM group, indicating higher risk aversion in the T2DM group.
Diﬀerences are signiﬁcant for one CE in the gain domain (j= 5; p-
value< 0.01) and two CEs in the loss domain (j= 2; p-value=0.034;
j= 5; p-value=0.093).
4.3.2. Utility parameters
Table 7 reports the median utility parameters, based on the in-
dividual data. The median coeﬃcients were signiﬁcantly diﬀerent from
0 for gains (γ = 3.46, p < 0.01) and losses (δ = 1.91, p < 0.01), but
were not signiﬁcantly diﬀerent from each other (p= 0.84). The dis-
tributions of individual utility parameters are provided in Appendix B -
Fig. 1. Probability weighting was signiﬁcant in the gain domain ( +ω =
0.49; p < 0.01).
Overall, a large majority of subjects had concave utility functions in
both domains (see Table 8). In the T2DM group, in particular, only 11
subjects (21%) had a convex utility in one of the two domains.
4.4. Loss aversion
We observed a high degree of risk aversion in the mixed prospect,
with 86% of the responses being risk averse. Only 11 [5] individuals
(10% [5%]) were risk seeking [risk neutral]. The median coeﬃcient for
loss aversion is signiﬁcantly diﬀerent from 1 (λ = 1.19; p < 0.01; see
Table 7). Appendix B - Fig. 2 shows the distribution of individual
coeﬃcients for loss aversion.
4.5. Risk attitudes and observable characteristics
Table 9 shows the results of OLS regressions performed on each of
the ﬁve parameters of interest. We studied the impact of ﬁve variables:
1) gender; 2) age (see Appendix D for more details on the age dis-
tribution); 3) T2DM status; 4) education; and 5) employment.
Table 4
Characteristics of the participants.
T2DM group Control group Total
Sample size 52 58 110
Gender Male 32 (61.5%) 28 (48.3%) 60 (54.5%)
Female 20 (38.5%) 30 (51.7%) 50 (45.5%)
Age Median [IQ1-IQ3] 53.5 [46–57.75] 50 [36–56] 51.5 [40–57]
Employment Employed (full time, part time) 39 (75%) 48 (82.8%) 87 (79.1%)
Unemployed (looking for job, retired, disabled) 13 (25%) 10 (17.2%) 23 (20.9%)
Education High school degree or no degree 20 (38.5%) 18 (31%) 38 (34.5%)
Bachelor or graduate degree 32 (61.5%) 40 (69%) 72 (65.5%)
Reliability 5/5 37 (71.2%) 49 (84.5%) 86 (78.2%)
4/5 15 (28.8%) 9 (15.5%) 24 (21.8%)
Duration (min) Mean [SD] 21.5 [6.1] 20.9 [7.8] 21.2 [7.0]
Table 5
Classiﬁcation of subjects according to their risk category, for each domain.
Losses
Risk averse Risk neutral Risk seeking Mixed Total
T2DM group
Gains
Risk averse 30 1 1 7 39
Risk neutral 0 0 0 0 0
Risk seeking 0 0 1 0 1
Mixed 3 0 4 5 12
Total 33 1 6 12 52
Control group
Gains
Risk averse 24 0 2 12 38
Risk neutral 0 0 0 0 0
Risk seeking 1 0 2 3 6
Mixed 3 1 1 9 14
Total 28 1 5 24 58
Table 6
Median CEs (absolute values) and Wilcoxon tests on the diﬀerence between gains and losses.
CEs T2DM group Control group Total
Gains Losses p-value Gains Losses p-value Gains Losses p-value
j=1 Median (IQ1-
IQ3)
2.50 (0.63–3.00) 0.75 (0.25–2.75) < 0.001*** 2.50 (0.50–3.31) 2.00 (0.25–3.32) 0.06* 2.50 (0.50–3.06) 1.25 (0.25–3.00) < 0.001***
j=2 Median (IQ1-
IQ3)
3.00 (1.25–4.50) 3.50 (0.63–5.00) 0.45 4.00 (2.00–5.00) 4.50 (2.44–5.50) 0.26 3.50 (2.00–4.50) 4.50 (2.00–5.50) 0.17
j=3 Median (IQ1-
IQ3)
3.00 (1.75–5.50) 3.00 (1.00–6.00) 0.85 4.00 (1.25–6.00) 5.25 (3.00–6.00) 0.86 4.00 (1.25–6.00) 4.50 (1.13–6.00) 0.96
j=4 Median (IQ1-
IQ3)
5.25 (5.00–8.25) 8.75
(5.00–10.00)
0.026** 7.00 (5.00–9.00) 8.75
(6.31–10.00)
0.009*** 6.50 (5.00–9.00) 8.75
(5.00–10.00)
< 0.001***
j=5 Median (IQ1-
IQ3)
9.00
(9.00–10.00)
10.50
(9.00–12.38)
< 0.001*** 10.00
(9.00–12.00)
12.00
(9.00–12.13)
0.02** 9.00
(9.00–12.00)
11.25
(9.00–12.13)
< 0.001***
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Firstly, we observed a clear age eﬀect on risk aversion coeﬃcients.
The older the individual, the higher the risk aversion coeﬃcient for
both the gain (p < 0.01 for both group categories) and the loss domain
(p=0.06 for the senior group eﬀect and p=0.01 for the veteran group
eﬀect). Secondly, people with T2DM were characterized by stronger
probability underweighting in the gain domain, which suggests higher
risk aversion than controls, on average, in this domain (p= 0.01).
Thirdly, signiﬁcant interactions between education level and employ-
ment status suggest the presence of underlying subgroup eﬀects. In
order to further investigate the eﬀects of age and T2DM status on risk
aversion, we performed additional OLS regressions to check whether
these results held when including only participants in the sample who
provided fully consistent answers (i.e. excluding people who provided
one inconsistent answer). Results displayed in Appendix E conﬁrmed
the existence of both eﬀects.
5. Discussion
5.1. Novelty
Our study extends previous research on decision-making under
health risks in two ways. First, we expand on previous work in-
vestigating risk attitudes and PT utility in the health domain by
building the prospects upon more realistic scenarios (decision on
whether or not to adopt self-management behaviour faced by people
living with a manageable chronic disease) and using health outcomes
that include both dimensions of health utility: life duration and QoL.
Second, while previous studies used a student or general population,
our study population was selected to allow comparisons between
people living with a manageable chronic disease (i.e. patients actually
facing such risky choices) and people without chronic disease. These
aspects are crucial in the perspective of bridging theoretical results and
actual policy-making. A key research axis of behavioural economics,
Table 7
Estimation results for the parameters of interest.
γ +ω δ −ω λ
T2DM group (n=52) Median (IQ1-IQ3) 3.81 (1.45–9.94) 0.49 (0.48–0.50) 2.83 (0.77–8.14) 0.50 (0.49–0.50) 1.19 (0.91–2.43)
Control group (n= 58) Median (IQ1-IQ3) 2.86 (0.47–6.86) 0.50 (0.49–0.50) 1.29 (−0.07–3.69) 0.50 (0.49–0.51) 1.19 (0.56–1.92)
Total (n= 110) Median (IQ1-IQ3) 3.46 (1.03–8.91) 0.49 (0.48–0.50) 1.91 (0.36–5.23) 0.50 (0.49–0.50) 1.19 (0.62–2.00)
Note 1: In the gain domain, u(x) concave [linear, convex] if x > 0 [x= 0, x < 0]. In the loss domain, u(x) concave [linear, convex] if x < 0 [x=0, x > 0].
Note 2: Loss aversion [neutral, seeking] when λ>1 [λ=1, λ<1,].
Note 3: All coeﬃcients were signiﬁcantly (p < 0.01) diﬀerent from 0 (γ and δ), 0.5 ( +ω and −ω ), and 1 (λ).
Table 8
Classiﬁcation of subjects according to their utility functions.
Losses
Concave Convex Total
T2DM group
Gains
Concave 43 6 49
Convex 1 2 3
Total 44 8 52
Control group
Gains
Concave 38 8 46
Convex 5 7 12
Total 43 15 58
Table 9
Ordinary least square regressions on the parameter estimates.
Dependent variable
γ +ω δ −ω λ
Gender
Male (reference) – – – – –
Female 2.683 (3.029) −0.003 (0.010) 0.951 (3.126) <0.001 (0.004) 0.948 (0.916)
Age
Junior (reference) – – – – –
Senior 9.330*** (3.368) −0.012 (0.010) 7.303* (3.822) 0.003 (0.005) −0.022 (0.534)
Veteran 11.327*** (3.719) −0.022 (0.016) 12.258** (4.673) −0.003 (0.005) 1.507 (1.379)
Group
T2DM (reference) – – – – –
Control −1.196 (2.935) 0.027** (0.010) −3.070 (3.240) <0.001 (0.004) 1.103 (1.577)
Employment
Not employed (reference) – – – – –
Employed 2.699 (5.419) −0.013 (0.033) 4.568 (7.929) <0.001 (0.008) −0.152 (0.603)
Education
High school degree or no degree (reference) – – – – –
Bachelor or graduate degree −10.821* (6.286) 0.034 (0.030) −11.782 (7.828) 0.007 (0.009) 4.619 (4.841)
Employment*Education
Not employed/High school degree or no degree (reference) – – – – –
Employed/Bachelor or graduate degree 13.240* (7.453) −0.032 (0.034) 15.031 (9.249) −0.005 (0.010) −4.440 (4.586)
Constant −2.173 (4.348) 0.477*** (0.016) 2.165 (5.050) 0.495*** (0.006) 0.055 (1.837)
Observations 110 110 110 110 110
R2 0.107 0.113 0.097 0.028 0.084
Prob > F 0.031 0.321 0.090 0.892 0.909
Note 1: *p < 0.1; **p < 0.05; ***p < 0.01.
Note 2: Gender categories (male=0; female= 1); age categories: junior (30–45 years old)= 0; senior (46–55 years old)= 1; veteran (56–60 years old)= 2; group
categories (T2DM=0; control= 1); education categories (high school degree or no degree=0; bachelor or graduate degree= 1); employment categories (not
employed=0; employed= 1).
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which is of primary interest here, is to ﬁnd ways of targeting identiﬁed
decision-making biases to nudge people towards a given (re-
commended) behaviour. By targeting the biases identiﬁed in this study,
more eﬀective interventions to encourage adherence to self-care be-
haviours in patient populations with manageable chronic disease may
be developed (see 5.4 for more details).
5.2. Risk attitudes
Our results show that participants expressed a high degree of risk
aversion, both in the gain and in the loss domains, and signiﬁcant loss
aversion. Two phenomena seem to explain this trend. Firstly, partici-
pants had very concave utility functions, which translated into high
utility parameters for both gains and losses. This is in line with previous
studies conducted on student (Attema et al., 2013) and general popu-
lations (Attema et al., 2016) and suggests that the role of the RP is less
crucial for health than for money. Another possibility is that, despite
making the RP as salient as possible in the instructions (use of visual
aids), people's own idea of how long they may live was still stronger
than the induced time horizon. More research that explicitly in-
vestigates this point is needed. Secondly, risk aversion was also re-
ﬂected in probability underweighting of probability 0.5 (only sig-
niﬁcant in the gain domain). Similar eﬀects were reported in the
abovementioned studies. Regarding loss aversion, our coeﬃcient is
comparable with those reported in the literature for the health domain
(Attema et al., 2013).
However, a feature speciﬁcally related to the study of risk attitude
for life years is that life years by deﬁnition involve a time component.
Consequently, the results will be aﬀected by time preferences. In fact,
the utility function for life duration can be regarded as reﬂecting both
diminishing returns to lifetime and discounting of future life years, and
it is hard to disentangle these eﬀects. The incorporation of losses in this
domain is particularly challenging, because only outcomes involving
future (as opposed to past) lifetime are useful and, therefore, the RP has
to be in the future in order to allow for losses. This creates two pro-
blems. First, because the changes in health occur at some point in the
future, the observed choices may have been diﬀerent if the changes had
taken eﬀect immediately. Second, the higher the loss, the closer one
gets to the present, so that as the individual moves farther away from
their RP, the inﬂuence of time preferences is reduced. As a result, the
concavity resulting from positive time preference will neutralize any
convexity inherent to losses, whereas there is no such inﬂuence of time
preference for monetary outcomes. This may explain why we ﬁnd
concave utility for losses on balance.
We have also performed robustness analyses to test for any eﬀect
caused by the onset of the health changes being only in 15 years for
gains. Table 1 in Appendix C shows the results, indicating no large
diﬀerences when allowing for discounting these 15 years. As a result,
one could argue that the S-shaped utility function typically found for
money does not apply to health, where the distinction between gains
and losses appears less inﬂuential. This does not detract from the robust
evidence of loss aversion found for health outcomes. Hence, the framing
of a question as a choice between the status quo and a mixed prospect
clearly induces more risk aversion than framing questions as choices
between two gain prospects or two loss prospects, even when the dis-
tinction between gains and losses appears less natural as in the case of
life duration. Table 2 in Appendix C illustrates this in more detail,
where the results of an additional analysis are presented that combines
the CEs of both the gain and the loss prospects to elicit one single utility
parameter and one single decision weight, while still using the results of
the mixed prospect to estimate loss aversion.
Moreover, two interesting subgroup eﬀects have been observed in
this study. Firstly, age was negatively related to risk attitudes. Splitting
our sample into three groups of equivalent size, as a compromise be-
tween tractability (i.e. beneﬁting from suﬃcient variability in the data)
and accuracy, signiﬁcant eﬀects were found on utility parameters for
gains and losses. Such eﬀects have already been reported in the health
domain: Dohmen et al. (2011) showed that older individuals express,
on average, higher risk aversion than younger individuals and Rolison
et al. (2013) found that health risk-taking reduces smoothly with age.
We examined a speciﬁc trade-oﬀ, in which choices were likely to be
inﬂuenced by age. The median age of the sample, combined with the RP
of living 20 more years, means that most subjects were asked to con-
template their life at (at least) age 70 and make decisions accordingly.
From this perspective, it is likely that the QoL dimension had more
weight than the life duration dimension in the decision-making process.
For an older subject, the prospect of living the last years of his/her life
with a constant, relatively good QoL (75%) was likely to be enough to
oﬀset the chance of living longer, i.e. the best outcome of the risky
option. Conversely, following the same reasoning, the QoL dimension
was less likely to prevail over the life duration dimension in decisions
made by younger subjects. Hence, younger subjects seem to care rela-
tively less about quality of life than older subjects, stressing the im-
portance of implementing age-speciﬁc health promotion policies.
Secondly, we found that people with T2DM were, on average, un-
derweighting probability 0.5 more strongly than controls, suggesting
higher risk aversion in the T2DM group. However, caution is required
about the interpretation of this eﬀect, as it was no longer signiﬁcant
when including only fully consistent subjects. Rather than revealing
diﬀerent underlying risk preferences between patients and controls, a
possible, alternative explanation is that the elicitation method could
have enhanced the observed T2DM eﬀect. Indeed, the higher degree of
risk aversion found with T2DM patients could be interpreted as a dif-
ference in terms of perception of the task, and more speciﬁcally as an
adjustment of their RP during the experiment. Since people with T2DM
had already ‘integrated’ the cost of behaviour change (they had already
had to change their behaviour), and although they were explicitly told
to forget about their condition and imagine living with perfect QoL at
the beginning of tasks 1 and 2, they could have implicitly taken 75% of
QoL, i.e. the QoL of the safe option, as their RP (as opposed to controls,
who took 100% of QoL as their RP). It is assumed that each individual
adjusts, to a certain extent, the RP according to her own situation, ex-
perience or perceptions; setting up a common RP allows to highlight
these diﬀerences. In that case, gain and loss prospects were possibly
interpreted as mixed prospects by some participants in the T2DM
group. Option A was seen as the status quo, and option B was seen as a
mixed prospect oﬀering the chance to ‘gain’ or ‘lose’ 25% of QoL. As a
consequence, because of loss aversion, this could have led to a higher
degree of risk aversion in the T2DM group. Future research could try to
avoid these problems; e.g. by eliciting respondents' reference points
before starting the main experiment and subsequently using these in-
dividual-speciﬁc RP to elicit risk preferences.
5.3. Strengths and limitations
The data in this study were collected following procedures intended
to ensure high quality. Firstly, the questionnaire was developed in
collaboration with both health professionals and patients in order to be
as user-friendly as possible. We used visual aids that facilitated parti-
cipants' understanding. Secondly, the experimenter running the inter-
view was continually present as a support for the participant,
throughout the questionnaire. He made sure that both the instructions
and the questions were well understood. This was a key aspect of the
procedure: no participant was asked to read the instructions or answer
the questions on their own. The written instructions were accompanied
by clear, additional verbal explanations. This translated into a large
majority of participants providing consistent answers for at least four
out of ﬁve CEs (92%). Despite a higher degree of complexity in the
design of the prospects, the reliability of our procedure compares to
those of earlier studies (Attema et al., 2013; Abdellaoui et al., 2008;
Stott, 2006).
On the other hand, the sample size is small, which limits the data
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analysis. Because T2DM usually arises in the early 60s, a major diﬃ-
culty of the study was to recruit patients with T2DM aged 60 or less,
and even more challenging, aged 50 or less. This constraint should be
taken into account when looking at the ﬁnal sample size of the T2DM
group (n= 52). We tried to ensure that controls were matched by age,
while also trying to minimise the risk of selection bias by recruiting
these participants randomly at the same surgery practice. Statistical
tests showed no between-group diﬀerences in terms of gender, em-
ployment status, education level, or answer reliability. Only a slight
diﬀerence in terms of age (the median age of the T2DM group was
higher) was found after exclusion of individuals who provided more
than one inconsistent answer. Individuals who were not fully consistent
in their answers (n= 30) turned out to be heterogeneous in terms of
demographic and socio-economic characteristics, which minimizes the
risk of selection bias and supports our elicitation procedure. However,
signiﬁcantly more individuals from the T2DM group had to be excluded
from the analysis than from the control group (8 participants vs 2
participants). Although caution is required in the interpretation of this
diﬀerence, it may be explained by underlying diﬀerences in terms of
cognitive abilities between people with T2DM and controls. Recent
studies have shown that diabetes impose a chronic negative eﬀect on
cognitive and decision-making skills (Chung et al., 2015; Hazari et al.,
2015; Rawlings et al., 2014). This should be borne in mind when de-
signing future studies involving cognitive tasks with T2DM populations.
Last, it is important to bear in mind other limitations inherent in the
elicitation method. Firstly, we designed the prospects using a broad
notion of health-related QoL, selecting three scores supposed to char-
acterise three QoL states. These scores were the result of a trade-oﬀ
between four criteria, including ease of understanding and realism.
Despite our eﬀorts to minimise rating biases, we could not completely
rule out individual variations in the way these scores were perceived.
For example, a QoL score of 100% is likely to be perceived diﬀerently
according to whether a person is 30 or 60 years old. One way of dealing
with this issue would be to elicit each individual's own QoL score before
running the experiment, and then use these personalised scores in the
prospects. Such an approach would, however, increase both the length
and the complexity of the experiment. Secondly, using only one single
probability (p= 0.5) in the prospects prevents conclusions from being
drawn about the decision weights attached to other probabilities. In
particular, the tendency of people to overweight low probabilities and
underweight high probabilities has been well-described in the literature
(Gonzalez and Wu, 1999). Thirdly, since separating the two attributes
(quality of life and life duration) and assessing their separate utility
functions would have caused a substantially higher response burden,
we analysed utilities of QALYs. That is, we assumed that the risk atti-
tude for quality of life was not systematically diﬀerent from the risk
attitude for life years. This is in contrast to the ﬁndings of van der Pol
and Ruggeri (2008), who reported risk seeking for quality of life
alongside risk aversion for life years. However, the evidence with re-
spect to risk attitudes regarding life years and quality of life is mixed,
with other evidence suggesting risk aversion over quality of life (Attema
et al., 2016). Furthermore, we expressed quality of life in percentages
whereas van der Pol and Ruggeri (2008) used EQ-5D classiﬁcations,
and our gambles did not include immediate death as opposed to the
lifetime gambles of van der Pol and Ruggeri (2008). It is therefore not
clear that their results also apply to our setting.
5.4. Recommendations
In the health domain, risky decisions made by people living with a
chronic disease may greatly impact their life expectancy and QoL.
Evidence of risk aversion found in this study suggests that risk seeking
behaviour may not explain lack of adherence to self-management ob-
served in T2DM populations. Although there is no data allowing us to
link the risk attitudes measured in this study with objective measures of
patients' self-management, participants preferred choosing the safer
option when facing scenarios that depict the risks inherent to each
behavioural option. In other words, when they can clearly visualize
(and thus be fully aware of) the risk associated with non-adherence,
people seem averse to it and prefer adhering to self-management. These
results suggest that in real life non-adherence to self-management may
be explained, at least partly, by an underestimation of the risks asso-
ciated with risky behaviour. In the medical literature, it has been shown
that T2DM patients largely underestimate the risks of diabetes-related
complications (Rouyard et al., 2017). One may argue that, regardless of
their level of risk perceptions, if these patients are risk seeking towards
behavioural choices associated with the management of their condition,
higher risk perceptions would not increase adherence to self-manage-
ment. Our study shows that this is not the case, i.e. that if patients had a
higher awareness of the risks associated with non-adherence to self-
management, they may change their behaviour. This does not ne-
cessarily contradict Simon-Tuval et al. (2016) who found an association
between risk-seeking behaviour for money and non-adherence to T2DM
self-management behaviour. Putting aside the diﬀerences between
utility for money and utility for health, it is possible that risk seeking
patients (both towards money and health) are also among the ones who
are the least adherent to self-management. However, our study shows
that this behaviour is uncommon when risky choices are speciﬁc to
T2DM self-management and hence may not be relevant to explain the
high rates of non-adherence observed in practice. Further research to
link elicited risk preferences for health outcomes with objective mea-
sures of adherence to self-management behaviour would be interesting.
A direct implication of our ﬁndings is that they support the design of
interventions that raise awareness of diabetes-related health risks and
take advantage of people's loss aversion. New risk communication
strategies that make the risk look more concrete and proximal are a
good example of how these two levers for action could be pulled. For
example, Spiegelhalter (2012) suggests providing patients with esti-
mates of how much lifetime they lose when they engage in risky be-
haviours. The concept of “microlife”, which represents half an hour of
adult life expectancy, was created to better communicate losses or gains
of lifetime associated with risky health behaviours (e.g. “a lifetime
habit of an extra portion of red meat per day is associated with a loss of
1 microlife per day”). This tool also presents the advantage of pulling
the present bias lever (Mørkbak et al., 2017), as higher or lower levels
of risk can be interpreted as “ageing faster or slower than an average
person”. Recently, a pilot randomised controlled trial was conducted in
primary care to assess the feasibility of using such new risk commu-
nication strategies with poorly controlled people with T2DM (Rouyard
et al., 2018). The objective of the intervention was to nudge this patient
population towards better adherence to self-management by targeting
some of the factors underlying such behaviour, including risk and loss
aversion. Personalised risk information was calculated based on a va-
lidated prognostic model and delivered to patients in an innovative
way. Traditional probabilistic risk information was converted into
metrics and formats more easily grasped by patients, including patients'
‘eﬀective heart age’ (Lopez-Gonzalez et al., 2015) instead of the more
abstract probability of experiencing a heart attack (pulling the risk
aversion lever) and daily losses of life time associated with lack of
adherence to self-care behaviours (pulling the loss aversion lever).
Recall of risk information after 3 months and intentions to change diet
were signiﬁcantly improved in the intervention group. This is a con-
crete example of how such information can be used, in practice and in
combination with other strategies, to increase adherence to self-care
behaviours in this particularly diﬃcult patient population.
Finally, the age-related diﬀerence in risk attitudes found in this
study suggests that a diﬀerent approach is needed for younger T2DM
patients. Because of lower risk aversion, such interventions are likely to
be less eﬀective in this population. Eﬀorts to develop alternative stra-
tegies should be of high priority, as worrying diﬀerences between
younger and older T2DM patients have been shown in terms of gly-
caemic control (Selvin and Parrinello, 2013) and onset of complications
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(Al Saeed et al., 2016; Copeland et al., 2013). This is partly due to lower
adherence to self-management (Villarroel et al., 2015) (that may be
caused by lower risk aversion and present preferences) and partly due
to younger-onset T2DM which is more aggressive by nature and thus
more challenging to control (Al Saeed et al., 2016; Copeland et al.,
2013).
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